We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
CME Group Inc (CME) is a leading financial data & stock exchanges business with stocks listed in the US. It opened the day at US$206.31 after a previous close of US$206.97. During the day the price has varied from a low of USD205.96 to a high of USD206.9. The latest price was USD206.28 (25 minute delay). CME Group is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in CME Group
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for CME Group. Find the share by name or ticker symbol: CME. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CME Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of CME Group, depending on your broker.
- Check in on your investment. Congratulations, you own a part of CME Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- CME Group key stats
- Compare share trading platforms
- Is CME Group stock a buy or sell?
- CME Group performance over time
- Can I short CME Group shares?
- Is CME Group suitable for ethical investing?
- Are CME Group shares over-valued?
- CME Group's financials
- How volatile are CME Group shares?
- Does CME Group pay a dividend?
- Have CME Group shares ever split?
- Other common questions
CME Group share priceUse our graph to track the performance of CME stocks over time.
CME Group shares at a glance
|52-week range||US$144.1823 - US$216.75|
|50-day moving average||US$205.9491|
|200-day moving average||US$184.2984|
|Dividend yield||US$3.4 (1.64%)|
|Earnings per share (TTM)||US$5.87|
Compare share trading platforms to buy stock
Is it a good time to buy CME Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
CME Group price performance over time
|1 week (2021-04-15)||1.09%|
|1 month (2021-03-19)||1.79%|
|3 months (2021-01-22)||12.08%|
|6 months (2020-10-22)||26.18%|
|1 year (2020-04-22)||14.99%|
|2 years (2019-04-22)||18.02%|
|3 years (2018-04-20)||24.96%|
|5 years (2016-04-22)||118.98%|
Is CME Group under- or over-valued?
Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CME Group's P/E ratio
CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, CME Group shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CME Group's PEG ratio
CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CME Group's EBITDA
CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.1 billion (£2.3 billion).
The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.
CME Group financials
|Revenue TTM||US$4.9 billion|
|Operating margin TTM||54.89%|
|Gross profit TTM||US$4.9 billion|
|Return on assets TTM||1.67%|
|Return on equity TTM||8.02%|
|Market capitalisation||US$73.5 billion|
TTM: trailing 12 months
Shorting CME Group shares
There are currently 5.3 million CME Group shares held short by investors – that's known as CME Group's "short interest". This figure is 4% up from 5.1 million last month.
There are a few different ways that this level of interest in shorting CME Group shares can be evaluated.
CME Group's "short interest ratio" (SIR)
CME Group's "short interest ratio" (SIR) is the quantity of CME Group shares currently shorted divided by the average quantity of CME Group shares traded daily (recently around 1.8 million). CME Group's SIR currently stands at 2.86. In other words for every 100,000 CME Group shares traded daily on the market, roughly 2860 shares are currently held short.
However CME Group's short interest can also be evaluated against the total number of CME Group shares, or, against the total number of tradable CME Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CME Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 CME Group shares in existence, roughly 10 shares are currently held short) or 0.0147% of the tradable shares (for every 100,000 tradable CME Group shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CME Group.
Find out more about how you can short CME Group stock.
CME Group's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
CME Group's total ESG risk score
Total ESG risk: 16.2
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 12/31/2018) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CME Group's environmental score
Environmental score: 6.41/100
CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
CME Group's social score
Social score: 9.64/100
CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
CME Group's governance score
Governance score: 8.65/100
CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
CME Group's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||16.2|
|Total ESG percentile||9.8|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||1|
CME Group share dividends
Dividend payout ratio: 75.78% of net profits
Recently CME Group has paid out, on average, around 75.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 1.74% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $3.4 per share.
CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
CME Group's most recent dividend payout was on 24 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 March 2021 (the "ex-dividend date").
Have CME Group's shares ever split?
CME Group's shares were split on a 5:1 basis on 22 July 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.
CME Group share price volatility
Over the last 12 months, CME Group's shares have ranged in value from as little as US$144.1823 up to US$216.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.4749. This would suggest that CME Group's shares are less volatile than average (for this exchange).
CME Group overview
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.A. to develop risk management products for Brazilian domestic and international market participants. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Frequently asked questions
Ask an Expert